TD Cowen has increased its price objective for Colgate-Palmolive Company (NYSE:CL) to $96.00 from $86.00 and left its Buy rating unchanged. The revised target provides only modest upside compared with the stock's trading price of $90.29, a security that has returned 14.96% so far this year.
The brokerage pointed to a narrow fourth-quarter earnings beat and 2026 guidance that aligns with a sequential improvement toward mid-single-digit EPS growth at the high end of the companys guidance range. TD Cowens internal update raised its fiscal 2026 EPS projection to $3.87, implying about 5% growth, and retained its positive stance on the shares.
Third-party InvestingPro estimates show analysts collectively forecasting EPS of $3.82 for fiscal 2026, a figure that TD Cowens revised estimate closely matches. The firm emphasized a set of operational and macro drivers that underpin its outlook, including strong execution across Latin America, ongoing recovery in India and China, restrained cost inflation, and supportive foreign exchange trends. TD Cowen described these elements as offering above-peer earnings clarity and flexibility.
InvestingPro data cited by the research firm also highlights Colgate-Palmolives robust gross profit margin of 60.11%, a metric TD Cowen uses to support its expectations for continued earnings resilience.
In its public results for fourth-quarter 2025, Colgate-Palmolive posted earnings per share of $0.95, outperforming the consensus estimate of $0.91. Revenue for the quarter came in at $5.23 billion, above the projected $5.12 billion. Those outcomes were referenced by analysts and appear to have reinforced TD Cowens assessment of the company's near-term trajectory.
Taken together, the guidance, margin profile, and regional performance appear to have convinced TD Cowen that Colgate-Palmolive can deliver modest EPS growth into fiscal 2026. The upgrade in the price target and the elevation of the firms EPS estimate reflect that view, while the maintained Buy rating signals continued conviction in the stocks prospects despite the limited incremental upside from current levels.
The market reaction to these analyst moves and the quarterly beat is consistent with investor attention to companies that combine stable margins and improving top-line momentum, particularly when trading near multi-month gains year-to-date.